Moderna (MRNA) PT Raised to $30 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $106.18 -2.45%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Moderna (NASDAQ: MRNA) to $30.00 (from $29.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities
- Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
- Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
